Discovery of Potential Natural Therapeutics Targeting Cell Wall Biosynthesis in Multidrug-resistant Enterococcus Faecalis: a Computational Perspective

Overview

Journal Biol Direct

Publisher Biomed Central

Specialty Biology

Date 2024 Nov 6

PMID 39501412

Authors

Km Rakhi

Monika Jain

Amit Kumar Singh

Mohd Sajid Ali

Hamad A Al-Lohedan

Jayaraman Muthukumaran

Affiliations

Soon will be listed here.

Abstract

Background: Identifying therapeutic inhibitors of crucial enzymes involved in the peptidoglycan biosynthesis pathway is pivotal for developing new treatments against multidrug-resistant Enterococcus faecalis V583. MurM, an essential enzyme in this pathway, plays a significant role in the bacterium's cell wall synthesis, making it an attractive druggable target for novel antimicrobial strategies. This study explored the potential of natural compounds as inhibitors of MurM, aiming to discover promising drug candidates that could serve as the foundation for future therapeutic development.

Methods: The three-dimensional structure of MurM was predicted, optimized, and its binding pocket was analyzed by comparing it with related structures. Over 4,70,000 natural compounds from the COCONUT database were subjected to virtual high-throughput screening (vHTS). The top lead candidates were selected based on their Lipinski's profile, ADME profile, toxicity profile, estimated binding free energy (ΔG) and estimated inhibition constant (Ki). Interaction pattern analysis was used to evaluate the non-covalent interactions between the inhibitors and key residues in MurM's binding pocket. Molecular dynamics simulations were performed over 300 ns to assess the structural stability and impact of these inhibitors on MurM's enzyme.

Results: Three lead compounds-CNP0056520, CNP0126952, and CNP0248480-were identified and prioritized with estimated ΔG ranging from - 9.35 to -7.9 kcal/mol. Molecular dynamics simulations revealed minimal impact on MurM's overall structure and dynamics, with the candidate inhibitors forming stable protein-ligand complexes. These interactions were supported by several non-covalent interactions between the candidate inhibitors and key residues within MurM's binding pocket.

Conclusion: These findings suggest that the identified natural product candidates could serve as promising inhibitors of MurM, potentially leading to novel therapeutics targeting cell wall biosynthesis in multidrug-resistant E. faecalis.

References

Navarre W, Schneewind O . Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999; 63(1):174-229. PMC: 98962. DOI: 10.1128/MMBR.63.1.174-229.1999. View

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View

Hunt C . The emergence of enterococci as a cause of nosocomial infection. Br J Biomed Sci. 1999; 55(2):149-56. View

Daina A, Michielin O, Zoete V . SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 7:42717. PMC: 5335600. DOI: 10.1038/srep42717. View

MacKerell Jr A, Banavali N, Foloppe N . Development and current status of the CHARMM force field for nucleic acids. Biopolymers. 2002; 56(4):257-65. DOI: 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W. View

Vollmer W, Blanot D, de Pedro M . Peptidoglycan structure and architecture. FEMS Microbiol Rev. 2008; 32(2):149-67. DOI: 10.1111/j.1574-6976.2007.00094.x. View

Km Rakhi , Bhati R, Jain M, Singh A, Muthukumaran J . Unveiling MurM inhibitors in V583: a promising approach to tackle antibiotic resistance. J Biomol Struct Dyn. 2024; :1-17. DOI: 10.1080/07391102.2024.2415686. View

Zoete V, Cuendet M, Grosdidier A, Michielin O . SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011; 32(11):2359-68. DOI: 10.1002/jcc.21816. View

Laskowski R . PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res. 2000; 29(1):221-2. PMC: 29784. DOI: 10.1093/nar/29.1.221. View

10.

Abascal J, Vega C . A general purpose model for the condensed phases of water: TIP4P/2005. J Chem Phys. 2006; 123(23):234505. DOI: 10.1063/1.2121687. View

11.

York A, Lloyd A, Del Genio C, Shearer J, Hinxman K, Fritz K . Structure-based modeling and dynamics of MurM, a Streptococcus pneumoniae penicillin resistance determinant present at the cytoplasmic membrane. Structure. 2021; 29(7):731-742.e6. PMC: 8280954. DOI: 10.1016/j.str.2021.03.001. View

12.

Kumari R, Dalal V . Identification of potential inhibitors for LLM of : structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies. J Biomol Struct Dyn. 2021; 40(20):9833-9847. DOI: 10.1080/07391102.2021.1936179. View

13.

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

14.

Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J . Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins. 2009; 77 Suppl 9:114-22. PMC: 2922016. DOI: 10.1002/prot.22570. View

15.

Rice L, Carias L, Rudin S, Vael C, Goossens H, Konstabel C . A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis. 2003; 187(3):508-12. DOI: 10.1086/367711. View

16.

Sahm D, Kissinger J, Gilmore M, Murray P, Mulder R, Solliday J . In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother. 1989; 33(9):1588-91. PMC: 172707. DOI: 10.1128/AAC.33.9.1588. View

17.

Aakra A, Vebo H, Snipen L, Hirt H, Aastveit A, Kapur V . Transcriptional response of Enterococcus faecalis V583 to erythromycin. Antimicrob Agents Chemother. 2005; 49(6):2246-59. PMC: 1140525. DOI: 10.1128/AAC.49.6.2246-2259.2005. View

18.

. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2022; 51(D1):D523-D531. PMC: 9825514. DOI: 10.1093/nar/gkac1052. View

19.

Dalal V, Dhankhar P, Singh V, Rakhaminov G, Golemi-Kotra D, Kumar P . Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM. Protein J. 2021; 40(2):148-165. DOI: 10.1007/s10930-020-09953-6. View

20.

Seeliger D, de Groot B . Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010; 24(5):417-22. PMC: 2881210. DOI: 10.1007/s10822-010-9352-6. View